149 related articles for article (PubMed ID: 15828228)
21. PPARs and the kidney in metabolic syndrome.
Ruan X; Zheng F; Guan Y
Am J Physiol Renal Physiol; 2008 May; 294(5):F1032-47. PubMed ID: 18234957
[TBL] [Abstract][Full Text] [Related]
22. A gut feeling of the PXR, PPAR and NF-kappaB connection.
Wahli W
J Intern Med; 2008 Jun; 263(6):613-9. PubMed ID: 18479261
[TBL] [Abstract][Full Text] [Related]
23. PPAR-alpha and -gamma but not -delta agonists inhibit airway inflammation in a murine model of asthma: in vitro evidence for an NF-kappaB-independent effect.
Trifilieff A; Bench A; Hanley M; Bayley D; Campbell E; Whittaker P
Br J Pharmacol; 2003 May; 139(1):163-71. PubMed ID: 12746235
[TBL] [Abstract][Full Text] [Related]
24. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis.
Staumont-Sallé D; Abboud G; Brénuchon C; Kanda A; Roumier T; Lavogiez C; Fleury S; Rémy P; Papin JP; Bertrand-Michel J; Tercé F; Staels B; Delaporte E; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2008 Apr; 121(4):962-8.e6. PubMed ID: 18249437
[TBL] [Abstract][Full Text] [Related]
26. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs.
Tham DM; Martin-McNulty B; Wang YX; Wilson DW; Vergona R; Sullivan ME; Dole W; Rutledge JC
Physiol Genomics; 2002 Oct; 11(1):21-30. PubMed ID: 12361987
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
29. PPAR receptor activation: Experimental studies on cardiac structure and function.
Bishop-Bailey D
Curr Opin Investig Drugs; 2010 Mar; 11(3):283-8. PubMed ID: 20178041
[TBL] [Abstract][Full Text] [Related]
30. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
Tan NS; Michalik L; Desvergne B; Wahli W
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):99-105. PubMed ID: 15860251
[TBL] [Abstract][Full Text] [Related]
31. Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.
Mandard S; Stienstra R; Escher P; Tan NS; Kim I; Gonzalez FJ; Wahli W; Desvergne B; Müller M; Kersten S
Cell Mol Life Sci; 2007 May; 64(9):1145-57. PubMed ID: 17437057
[TBL] [Abstract][Full Text] [Related]
32. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
33. PPARs: the vasculature, inflammation and hypertension.
Duan SZ; Usher MG; Mortensen RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):128-33. PubMed ID: 19434050
[TBL] [Abstract][Full Text] [Related]
34. Proinflammatory cytokine and ligands modulate cardiac peroxisome proliferator-activated receptors.
Lee TI; Kao YH; Chen YC; Chen YJ
Eur J Clin Invest; 2009 Jan; 39(1):23-30. PubMed ID: 19067734
[TBL] [Abstract][Full Text] [Related]
35. PPARs and molecular mechanisms of transrepression.
Ricote M; Glass CK
Biochim Biophys Acta; 2007 Aug; 1771(8):926-35. PubMed ID: 17433773
[TBL] [Abstract][Full Text] [Related]
36. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
[TBL] [Abstract][Full Text] [Related]
37. Epoxygenases and peroxisome proliferator-activated receptors in mammalian vascular biology.
Wray J; Bishop-Bailey D
Exp Physiol; 2008 Jan; 93(1):148-54. PubMed ID: 17872966
[TBL] [Abstract][Full Text] [Related]
38. [PPARs target genes].
Takada I; Kato S
Nihon Rinsho; 2005 Apr; 63(4):573-7. PubMed ID: 15828222
[TBL] [Abstract][Full Text] [Related]
39. PPARs as drug targets to modulate inflammatory responses?
Genolet R; Wahli W; Michalik L
Curr Drug Targets Inflamm Allergy; 2004 Dec; 3(4):361-75. PubMed ID: 15584886
[TBL] [Abstract][Full Text] [Related]
40. PPARs special issue: anchoring the present to explore the future.
Desvergne B
Biochim Biophys Acta; 2007 Aug; 1771(8):913-4. PubMed ID: 17689831
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
